Canbakan B - Search Results

1

Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B.

Atay K, Hatemi İ, Canbakan B, Köroğlu E, Durcan E, Yurttaş B, Gültepe İ, Özdemir S, Tuncer M, Sonsuz A. Atay K, et al. Among authors: canbakan b. Turk J Gastroenterol. 2016 May;27(3):279-83. doi: 10.5152/tjg.2016.16085. Turk J Gastroenterol. 2016. PMID: 27210786 Free article.

2

[Blindness as a complication of hepatic encephalopathy].

Canbakan B, Canbakan M, Oz V, Tuncer M, Demir M. Canbakan B, et al. Among authors: canbakan m. Wien Med Wochenschr. 2001;151(18-20):477-80. Wien Med Wochenschr. 2001. PMID: 11817261 German.

3

Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: a randomized trial.

Canbakan B, Senturk H, Tabak F, Akdogan M, Tahan V, Mert A, Sut N, Ozaras R, Midilli K, Ozbay G. Canbakan B, et al. J Gastroenterol Hepatol. 2006 Apr;21(4):657-63. doi: 10.1111/j.1440-1746.2006.04082.x. J Gastroenterol Hepatol. 2006. PMID: 16677149 Clinical Trial.

4

Liver steatosis in hepatitis C positive hemodialysis patients and factors affecting IFN-2a treatment.

Yildirim B, Durak H, Ozaras R, Canbakan B, Ozkan P, Ozbay G, Senturk H. Yildirim B, et al. Among authors: canbakan b. Scand J Gastroenterol. 2006 Oct;41(10):1235-41. doi: 10.1080/00365520600670034. Scand J Gastroenterol. 2006. PMID: 16990211

5

Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease.

Canbakan B, Senturk H, Tahan V, Hatemi I, Balci H, Toptas T, Sonsuz A, Velet M, Aydin S, Dirican A, Ozgulle S, Ozbay G. Canbakan B, et al. Acta Gastroenterol Belg. 2007 Jul-Sep;70(3):277-84. Acta Gastroenterol Belg. 2007. PMID: 18074737

6

Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.

Senturk H, Tahan V, Canbakan B, Uraz S, Ulger Y, Ozaras R, Tabak F, Mert A, Ozbay G. Senturk H, et al. Among authors: canbakan b. Neth J Med. 2008 May;66(5):191-5. Neth J Med. 2008. PMID: 18490796 Free article.

7

Leptin in nonalcoholic fatty liver disease.

Canbakan B, Tahan V, Balci H, Hatemi I, Erer B, Ozbay G, Sut N, Hacibekiroglu M, Imeryuz N, Senturk H. Canbakan B, et al. Ann Hepatol. 2008 Jul-Sep;7(3):249-54. Ann Hepatol. 2008. PMID: 18753993 Free article.

8

Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.

Tahan V, Canbakan B, Balci H, Dane F, Akin H, Can G, Hatemi I, Olgac V, Sonsuz A, Ozbay G, Yurdakul I, Senturk H. Tahan V, et al. Among authors: canbakan b. Hepatogastroenterology. 2008 Jul-Aug;55(85):1433-8. Hepatogastroenterology. 2008. PMID: 18795706

9

Long-term effect of interferon therapy in patients with HBeAg positive chronic hepatitis B infection.

Senturk H, Baysal B, Tahan V, Zerdali H, Ozaras R, Tabak F, Mert A, Canbakan B, Tabak O, Ozbay G. Senturk H, et al. Among authors: canbakan b. Dig Dis Sci. 2011 Jan;56(1):208-12. doi: 10.1007/s10620-010-1255-9. Epub 2010 May 14. Dig Dis Sci. 2011. PMID: 20467899

10

The role of EUS and EUS-FNA in the management of pancreatic masses: five-year experience.

Caglar E, Senturk H, Atasoy D, Şişman G, Canbakan BI, Tuncer M. Caglar E, et al. Hepatogastroenterology. 2013 Jun;60(124):896-9. doi: 10.5754/hge121100. Epub 2013 Jan 24. Hepatogastroenterology. 2013. PMID: 23321061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters